A recent study has found that flavonoids isolated from Psoralea corylifolia are able to inhibit part of the insulin pathway.
Seeds of the P. corylifolia plant have been used in eastern medicine, primary in China, for years, and is now being further researched as flavonoids continue to intrigue researchers with their possible therapeutic benefits. The inhibitory activity found in this study provides evidence that flavonoids should be pursued as a potential treatment for Type-2 Diabetes.
View this review (yellow link) or download:
New compounds from the seeds of Psoralea Corylifolia with their protein tyrosine phosphatase 1B inhibitory activityDownload
This paper is also stored here: http://bit.ly/2KORB1v inside the CED Foundation Archive
To explore related information, click the keywords below: